NCT00015301View on ClinicalTrials.gov

Methylphenidate Raclopride Positron Emission Tomography (PET) Test - 11

PHASE4CompletedINTERVENTIONAL
0
Timeline

Start Date

December 31, 2003

Primary Completion Date

June 30, 2005

Study Completion Date

August 31, 2005

Conditions
Cocaine-Related DisordersSubstance-Related Disorders
Interventions
DRUG

Methylphenidate

Trial Locations (1)

10010

New York MDRU, New York

All Listed Sponsors
collaborator

New York MDRU

OTHER

lead

National Institute on Drug Abuse (NIDA)

NIH

NCT00015301 - Methylphenidate Raclopride Positron Emission Tomography (PET) Test - 11 | Biotech Hunter | Biotech Hunter